Lomitapide Mesylate

CAS 202914-84-9 2 current recordsSmall Molecule

Who holds supplier records for Lomitapide Mesylate? 2 organisations hold a current record for Lomitapide Mesylate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Lomitapide Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/lomitapide-mesylate

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 2 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lomitapide Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Lomitapide Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lomitapide Mesylate is an inhibitor of microsomal triglyceride transfer protein and is used as an adjunct to a low-fat diet and other lipid-lowering treatments for the prevention and chronic management of hyperlipidemia. It reduces levels of cholesterol by limiting the secretion of triglyceride-rich lipoproteins into the bloodstream.

Chemical identity

IUPAC name
methanesulfonic acid;N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide
Canonical SMILES
CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F
InChIKey
QKVKOFVWUHNEBX-UHFFFAOYSA-N
Synonyms
Juxtapid API, aegr-733 mesilate, aegr-733 mesylate, bms-201038, bms-201038-04, lomitapide mesilate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Microsomal Triglyceride Transfer Protein Inhibitor
Mechanism of action
Cytochrome P450 3A4 Inhibitors; Microsomal Triglyceride Transfer Protein Inhibitors; P-Glycoprotein Inhibitors

Therapeutic areas

Cardiovascular DiseasesLipid Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lomitapide Mesylate?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Lomitapide Mesylate: ALIVUS LIFE SCIENCES LTD (India) and MAITHRI DRUGS PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lomitapide Mesylate Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 30272) and MAITHRI DRUGS PRIVATE LTD (DMF 31454). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Lomitapide Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lomitapide Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.